M.L. McKean

880 total citations
9 papers, 732 citations indexed

About

M.L. McKean is a scholar working on Molecular Biology, Biochemistry and Pathology and Forensic Medicine. According to data from OpenAlex, M.L. McKean has authored 9 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Biochemistry and 2 papers in Pathology and Forensic Medicine. Recurrent topics in M.L. McKean's work include Eicosanoids and Hypertension Pharmacology (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Muscle metabolism and nutrition (2 papers). M.L. McKean is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Muscle metabolism and nutrition (2 papers). M.L. McKean collaborates with scholars based in United States and United Kingdom. M.L. McKean's co-authors include William R. Nes, M.J. Silver, J. Bryan Smith, David G. Ahern, Kalwant S. Authi, Melvin J. Silver, Neville Crawford, S J Adelman and Donald E. Clark and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

M.L. McKean

9 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.L. McKean United States 8 439 142 92 90 82 9 732
Seiji Nagao Japan 20 624 1.4× 66 0.5× 55 0.6× 48 0.5× 65 0.8× 48 1.1k
Philip K. Tubbs United Kingdom 26 1.2k 2.7× 184 1.3× 60 0.7× 53 0.6× 80 1.0× 61 1.8k
Mona E. Fewster United States 13 430 1.0× 92 0.6× 62 0.7× 25 0.3× 130 1.6× 21 873
A.G. Lowe United Kingdom 17 580 1.3× 78 0.5× 122 1.3× 25 0.3× 37 0.5× 32 987
J. Erbland United States 19 614 1.4× 283 2.0× 86 0.9× 40 0.4× 151 1.8× 31 1.0k
Metry Bacila Brazil 14 419 1.0× 122 0.9× 44 0.5× 34 0.4× 34 0.4× 81 865
M.F. Utter United States 22 882 2.0× 361 2.5× 69 0.8× 30 0.3× 49 0.6× 30 1.5k
David L. Busbee United States 20 582 1.3× 72 0.5× 29 0.3× 83 0.9× 52 0.6× 80 1.5k
N. H. Tattrie Canada 14 442 1.0× 162 1.1× 53 0.6× 30 0.3× 94 1.1× 25 728
G. Bruno Italy 9 276 0.6× 67 0.5× 34 0.4× 32 0.4× 34 0.4× 14 748

Countries citing papers authored by M.L. McKean

Since Specialization
Citations

This map shows the geographic impact of M.L. McKean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. McKean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. McKean more than expected).

Fields of papers citing papers by M.L. McKean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.L. McKean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. McKean. The network helps show where M.L. McKean may publish in the future.

Co-authorship network of co-authors of M.L. McKean

This figure shows the co-authorship network connecting the top 25 collaborators of M.L. McKean. A scholar is included among the top collaborators of M.L. McKean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.L. McKean. M.L. McKean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Adelman, S J, et al.. (1994). ACA-147: an inhibitor of ACAT and of the oxidative modification of LDL. Atherosclerosis. 109(1-2). 89–89. 3 indexed citations
2.
McKean, M.L., Melvin J. Silver, Kalwant S. Authi, & Neville Crawford. (1986). Formation of diacyl‐ and alkylacylphosphatidylcholine by the membranes of human platelets. FEBS Letters. 195(1-2). 38–42. 7 indexed citations
3.
McKean, M.L. & M.J. Silver. (1985). Phospholipid biosynthesis in human platelets. The acylation of lyso-platelet-activating factor. Biochemical Journal. 225(3). 723–729. 23 indexed citations
4.
McKean, M.L., J. Bryan Smith, & M.J. Silver. (1982). Phospholipid biosynthesis in human platelets. Formation of phosphatidylcholine from 1-acyl lysophosphatidylcholine by acyl-CoA:1-acyl-sn-glycero-3-phosphocholine acyltransferase.. Journal of Biological Chemistry. 257(19). 11278–11283. 67 indexed citations
5.
McKean, M.L., J. Bryan Smith, & M.J. Silver. (1981). Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid.. Journal of Biological Chemistry. 256(4). 1522–1524. 188 indexed citations
6.
McKean, M.L., J. Bryan Smith, M.J. Silver, & David G. Ahern. (1981). Metabolism of radioactive 5,8,11,14,17-eicosapentaenoic acid by human platelets. Progress in Lipid Research. 20. 435–438. 16 indexed citations
7.
McKean, M.L. & William R. Nes. (1977). Delayed conversion of squalene to sterols during development ofPinus pinea seeds. Lipids. 12(4). 382–385. 8 indexed citations
8.
McKean, M.L. & William R. Nes. (1977). Evidence for separate intermediates in the biosynthesis of 24α- and 24β-alkylsterols in tracheophytes. Phytochemistry. 16(6). 683–686. 36 indexed citations
9.
Nes, William R. & M.L. McKean. (1977). Biochemistry of steroids and other isopentenoids. Medical Entomology and Zoology. 384 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026